GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » Total Current Assets

Biohit Oyj (OHEL:BIOBV) Total Current Assets : €10.95 Mil (As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Biohit Oyj's total current assets for the quarter that ended in Dec. 2024 was €10.95 Mil.


Biohit Oyj Total Current Assets Historical Data

The historical data trend for Biohit Oyj's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj Total Current Assets Chart

Biohit Oyj Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.30 8.98 9.90 11.83 10.95

Biohit Oyj Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.90 11.40 11.83 12.90 10.95

Biohit Oyj Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Biohit Oyj's Total Current Assets for the fiscal year that ended in Dec. 2024 is calculated as

Biohit Oyj's Total Current Assets for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Biohit Oyj  (OHEL:BIOBV) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Biohit Oyj's Liquidation Value for the quarter that ended in Dec. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=6.71-3.311+0.75 * 1.724+0.5 * 1.029
=5.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biohit Oyj Total Current Assets Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Biohit Oyj Business Description

Traded in Other Exchanges
Address
Laippatie 1, Helsinki, FIN, 00880
Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds and monoclonal antibodies and service laboratory operations.

Biohit Oyj Headlines

No Headlines